Fair-Value Report — Kelfred Holdings Ltd. (1134.HK)

Insider Signal

Verified Snapshot

Data sources: FY2025 results announced 25 March 2026 (Globe and Mail / TipRanks sourcing HKEX filing). Balance sheet per investing.com / Google Finance cross-check. Price as of 17 Jun 2026 per Google Finance. All figures in HKD unless stated.

Business

Kelfred Holdings (founded 1986, listed HKEX Main Board) is an eyewear ODM/OEM manufacturer producing optical frames and sunglasses. Its principal operating subsidiaries include Kelfred Optical Ltd., Optical Farm HK Ltd., Huaqing Glasses (Shenzhen) Co., Ltd., and Jiangxi Huaqing Glasses Co., Ltd., plus a 50% JV, Central Designs (Hong Kong) Ltd.

The business model is purely B2B: Kelfred designs and manufactures frames for international and regional brands, competing primarily on price, design capability, and lead-time. Revenue is predominantly denominated in USD/foreign currencies while a significant cost base is RMB-denominated, creating structural FX exposure.

FY2025 highlights: Revenue grew ~10% to HKD 500.3M. Gross profit improved sharply to HKD 59.3M (gross margin 11.9% vs 9.9% in FY2024) — a meaningful recovery. Operating loss narrowed to HKD 11.1M from HKD 19.5M. However, net loss widened in H2 2025 (H1 loss: HKD 4.7M; full-year: HKD 15.2M → H2 loss: HKD 10.5M), a sequential deterioration that management attributed in part to RMB appreciation-driven exchange losses. The company secured a new sales agreement with DEM in 2026, signalling continued order momentum.

Key strength: Despite net losses, the company generates strong operating cash flow (HKD 28.4M in FY2025). Depreciation and non-cash charges of ~HKD 27–28M mask the cash generation ability. Net cash of HKD 35.4M (21% of market cap) provides a meaningful balance-sheet cushion.

Valuation

Method Rationale

Kelfred is a loss-making operating manufacturer. A free-cash-flow DCF is not appropriate — the loss trajectory is reversing but the path to sustained net profitability is not established. We use: (1) P/Book as the floor anchor; (2) EV/Operating Cash Flow as the primary business-value metric (OCF is positive and meaningful); (3) a path-to-profitability P/E scenario in the bull case; validated against a peer EV/Revenue multiple.

Key Valuation Inputs

Scenario Valuation Table

Bull equity value = EV + net cash (HKD 35.4M) ÷ 500M shares. P/B floor check: at 0.75× book (bear), FV = HKD 0.22; at 1.0× book (base), FV = HKD 0.30; at 1.3× book (bull), FV = HKD 0.39. OCF-based and P/B estimates are averaged. Weighted average: 0.25 × 0.49 + 0.50 × 0.35 + 0.25 × 0.22 = HKD 0.35.

Reverse Read

At HKD 0.34, the market is pricing Kelfred at 4.7× EV/OCF — implying an annualised OCF of roughly HKD 28M in perpetuity, growing at zero. That is a bearish steady-state assumption: if OCF normalises toward HKD 30–35M as revenue scales and margins inch higher, today's price embeds meaningful upside. Conversely, if OCF reverts to HKD 15M (H2 2025 run-rate extrapolated), the current multiple rises to ~9× — expensive for a loss-maker. The market is effectively saying "we believe today's OCF is sustainable but not improving." The bull thesis needs to disprove this.

Peer Comparison Table

Arts Optical data: FY2025 revenue HKD 1,333.9M (+4% YoY), net profit HKD 20.7M, market cap HKD 347.6M, gross margin 30.98%, D/E 37.6%. EV/Revenue and P/B are estimates due to partial data availability. Key observation: Arts Optical (profitable, 31% gross margin) trades at a lower EV/Revenue than Kelfred. This implies Kelfred carries a slight relative premium — partially explained by its proportionately larger net-cash balance (20.8% of market cap vs. smaller proportion for Arts Optical). On an operating-business basis, Arts Optical is a more attractive margin profile. This is a caution for Kelfred's valuation.

Conclusion — Hold

The insider signal is real: Tam Man Yee executed a genuine on-exchange purchase of 5.0% of Kelfred Holdings at HKD 0.35 per share on 10 June 2026, committing HKD 8.75M. She is most likely a member of the founding Kwok family, following a similar accumulation by Hon Yim Kwok in November 2024. The pattern suggests the controlling family is methodically building additional direct exposure beyond their ~54% via Conquer Holding — a mild positive signal on value confidence.

The operational story is improving: revenue grew ~10% in FY2025, gross margins expanded from 9.9% to 11.9%, and the operating loss narrowed. Operating cash flow of HKD 28.4M remained strong. However, the H2 2025 performance was weaker than H1 (H2 net loss of HKD 10.5M vs H1 loss of HKD 4.7M), driven partly by RMB appreciation and higher finance costs. The company is not yet at breakeven and the gross margin (12%) remains far below peer Arts Optical (31%), reflecting a structurally thinner business model in ODM/OEM.

At HKD 0.34, the stock trades at 1.14× book and 4.7× EV/OCF. The base-case fair value of HKD 0.35 is essentially in line with market. The bull scenario (HKD 0.49, +44%) requires OCF growth to HKD 35M+ — achievable if the new DEM sales agreement adds revenue and margins continue their recovery arc. The bear scenario (HKD 0.22, −35%) is live if FX losses worsen or orders slow.

Rating: Hold. The signal is supportive and the recovery thesis is credible, but the stock is priced at fair value, not a discount. Investors should watch H1 2026 interim results (expected August 2026) for confirmation of the recovery trend, particularly H2-2025 margin weakness resolution and OCF sustain above HKD 25M. A move toward breakeven net income would likely re-rate the stock toward HKD 0.40–0.49.

Key Risks

• RMB appreciation: Manufacturing costs are RMB-denominated; a strengthening RMB vs USD/HKD compresses already-thin margins and generates FX translation losses. H2 2025 evidenced this.
• Margin structural weakness: Gross margin of 11.9% is less than half that of peer Arts Optical (31%). ODM/OEM price pressure and rising labour costs in China make margin recovery challenging.
• Concentration / customer risk: Revenue is concentrated in key brand customers. Loss of a major account (e.g., DEM or others) could materially cut revenue.
• H2 deterioration pattern: Full-year FY2025 loss of HKD 15.2M vs H1-only loss of HKD 4.7M means H2 2025 was sharply weaker. If this seasonal/structural weakness recurs, the recovery thesis weakens.
• Opaque insider motive: The buyer is a connected/family party. Accumulation could signal conviction — or a pre-privatisation share aggregation that does not benefit minority investors.
• Micro-cap liquidity: Average daily volume ~156,000 shares (HKD ~53,000). Minimal sell-side coverage. Wide bid-ask spreads.
• Going concern is not an immediate risk (HKD 35.4M net cash, positive OCF), but sustained losses erode equity over time.

Sources

• HKEX DI screen signal data — candidate JSON (1134, Tam Man Yee, 10 Jun 2026)
• FY2025 annual results (year ended 31 Dec 2025, announced 25 Mar 2026) — The Globe and Mail / TipRanks sourcing HKEX filing
• H1 2025 interim results (six months ended 30 Jun 2025, announced Aug 2025) — TipRanks / HKEX news
• Balance sheet, ratios, market data — Investing.com (HK:1134), Google Finance (1134:HKG, as of 17 Jun 2026)
• Peer Arts Optical (1120.HK) — FY2025 data from search aggregators and Yahoo Finance
• Corporate structure / officers — etnet.com.hk, Bloomberg (Kwok Ken / Kwok Kwan Fai profiles)
• Shareholder data — search aggregator sourcing HKEX DI filings (Conquer Holding 54.2%, Hon Yim Kwok 5.04%)